GlassScriptPhysician profile
Laurissa Kashmer
NPI 1144434291
$8,215.38
in general payments reported to CMS, 2019-2025
18 companies · $6,356 in 2025
The $6,356 reported for 2025 was more than what 85% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $208 · 2022: $155 · 2023: $408 · 2024: $919 · 2025: $6,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,964 · Consulting Fee: $2,800 · Travel and Lodging: $1,876 · Gift: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,963.73 |
| Consulting Fee | $2,800.00 |
| Travel and Lodging | $1,875.90 |
| Gift | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $3,743.58 | 2025 | |
| Medtronic, INC. | $2,273.53 | 2023-2025 | Minimed 780g |
| Insulet Corporation | $564.75 | 2019-2025 | Omnipod, Omnipod |
| Novo Nordisk INC | $417.94 | 2019-2024 | Sogroya |
| Tandem Diabetes Care, INC. | $281.77 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sequel Med Tech, LLC | $257.24 | 2025 | Twiist |
| Biomarin Pharmaceutical INC. | $237.25 | 2023-2025 | Voxzogo 1.2mg |
| Abbott Laboratories | $150.10 | 2022-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $47.88 | 2024 | Dexcom G6 Transmitter |
| Beta Bionics, INC. | $45.54 | 2024 | Ilet Bionic Pancreas |
| Mannkind Corporation | $42.50 | 2024 | |
| Tolmar, INC. | $40.67 | 2023 | |
| Sanofi-Aventis U.S. LLC | $39.61 | 2023 | |
| Ibsa Pharma INC. | $17.80 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.40 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $17.32 | 2019 | |
| Lilly USA, LLC | $12.50 | 2019 | |
| Senseonics, Incorporated | $8.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurissa Kashmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.